<DOC>
	<DOCNO>NCT01695187</DOCNO>
	<brief_summary>This study test hypothesis time heal cold sore lower active treatment arm study compare vehicle ( placebo ) . Subjects history cold sore enrol administered active treatment placebo blind manner . Subjects follow assess time healing .</brief_summary>
	<brief_title>NB-001 Treatment Recurrent Herpes Labialis</brief_title>
	<detailed_description />
	<mesh_term>Herpes Labialis</mesh_term>
	<mesh_term>5- ( ( 2- ( 6- Amino- 9H- purin- 9- yl ) ethyl ) amino ) - 1- pentanol</mesh_term>
	<criteria>1 . Be healthy man woman 18 year age old . Women pregnant , lactate may become pregnant may ( investigator 's discretion ) include study ; 2 . Have recurrent herpes labialis defined history three ( 3 ) cold sore recurrence lips and/or skin surround lip previous year . The majority cold sore recurrence proceed welldefined history prodromal symptom include redness , pain , burning , tingle , itch , swell tight sensation lip site outbreak ; 3 . Be willing refrain use systemic topical antiviral agent systemic corticosteroid within 4 week prior study drug administration duration cold sore recurrence ; 4 . Be willing refrain use topical pharmaceutical cosmetic product study medication around nasal perioral area duration cold sore recurrence ; 5 . Be willing refrain participation another clinical trial ; 6 . Be willing able use phone internet obtain combination unlock study medication kit ; 7 . Be able read write English understand comply protocol requirement ; 8 . Be able give inform consent sign write informed consent form . 1 . Known hypersensitivity one drug ingredient , include soybean oil , polysorbate ( Tween ) , alcohol , EDTA , cetylpyridinium chloride ( found mouthwash lozenge ) ; 2 . Severe chronic illness include renal failure , severe respiratory cardiac disease , chronic infection , immunodeficiency syndrome , uncontrolled diabetes mellitus untreated severe thyroid disease ; 3 . Received ( within last 6 month ) receive chemotherapy ; 4 . Significant skin disease face ( atopic dermatitis , cystic acne , severe rosacea , eczema , psoriasis chronic vesiculobullous disorder ) lesion , wound , abrasion , piercings , tattoo , irritation skin condition around nasal perioral area would interfere treatment assessment primary lesion complex . Subjects mild controlled psoriasis , eczema , acne dermatitis condition may include condition interfere ability evaluate herpes labialis lesion local skin irritation ; 5 . Previously receive herpes vaccine ; 6 . Active alcohol drug abuse ; 7 . Prior randomization NanoBio study ; 8 . Any condition would potentially make unable participate entire trial period ; 9 . Known allergy topical cream , ointment topical medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Herpes , Herpes Labialis , nanoemulsion , NanoBio , NB-001</keyword>
</DOC>